The Massachusetts-based startup aims to advance testing for parasitic and viral diseases including Chagas, Zika, and Lyme, and tapeworm and liver fluke infections.
Kephera Diagnostics Gets $3M NIH Grant for Chagas Disease Test
The company previously received nearly $600,000 from the NIH to work on the test, which it now intends to validate in clinical studies in the US and Latin America.
Kephera Diagnostics Wins $300K NIH Grant for Chagas Disease Test
The test will be designed in both laboratory-based and point-of-care formats to address the needs of clinical and field settings.
The tests performed well, with researchers suggested they could be used for diagnosis in the future, rather than just screening.
Kephera Gets $594K NIH Grant for Determining Whether Chagas Patient Has Been Cured
Treatment of Chagas disease can be lengthy and there is currently no available method to confirm whether a patient has been cured, according to the firm.